Revised forecast
Fiscal year ending December 2026 · Full yearPrevious forecast published 13 February 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
The company was able to ensure a stable supply of products through securing raw materials and alternative sourcing, sales volumes remained firm, and expanded sales and product price revisions increased revenue. Although raw material prices and logistics costs rose, the effects of cost reductions from higher revenue, alternative raw materials and a review of production processes contributed to increases in operating income and ordinary income. Meanwhile, net income attributable to owners of the parent is expected to fall below the year-earlier period due to the recognition of impairment losses.
Impairment losses of ¥9,197 million (¥4,731 million at a consolidated subsidiary in Hungary, ¥2,595 million at a consolidated subsidiary in Turkey, and ¥1,869 million at a manufacturing facility in Japan)
| Item | Details |
|---|---|
| Net Sales | 360,000 Millions of yen → 388,000 Millions of yen（+7.8%） |
| Operating profit | 23,000 Millions of yen → 26,000 Millions of yen（+13.0%） |
| Ordinary income | 22,500 Millions of yen → 27,500 Millions of yen（+22.2%） |
| Profit attributable to owners of the parent | 21,000 Millions of yen → 19,000 Millions of yen（-9.5%） |
| Net income per share | 447.58 Yen/sen → 404.95 Yen/sen |
| Fiscal Period Covered | Fiscal year ending December 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 13 February 2026 |
| Previous-period results | Fiscal year ending December 2025: revenue ¥349,979 million; operating income ¥20,765 million; ordinary income ¥20,888 million; net income attributable to owners of the parent ¥10,340 million; earnings per share ¥210.50 |
| Reason for the revision | The company was able to ensure a stable supply of products through securing raw materials and alternative sourcing, sales volumes remained firm, and expanded sales and product price revisions increased revenue. Although raw material prices and logistics costs rose, the effects of cost reductions from higher revenue, alternative raw materials and a review of production processes contributed to increases in operating income and ordinary income. Meanwhile, net income attributable to owners of the parent is expected to fall below the year-earlier period due to the recognition of impairment losses. |
| Details and amount of extraordinary loss | Impairment losses of ¥9,197 million (¥4,731 million at a consolidated subsidiary in Hungary, ¥2,595 million at a consolidated subsidiary in Turkey, and ¥1,869 million at a manufacturing facility in Japan) |
| Dividend forecast revision | No revision. The full-year dividend forecast is ¥120 per share (interim dividend: ¥60; year-end dividend: ¥60). |
| Consolidated / non-consolidated | Consolidated |
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The reasons were that securing raw materials and alternative sourcing stabilized product supplies, sales volumes remained firm, and expanded sales and product price revisions increased revenue. Although raw material prices and logistics costs rose, the effects of cost reductions from higher revenue, alternative raw materials and a review of production processes pushed up operating income and ordinary income. Meanwhile, net income attributable to owners of the parent was revised downward because impairment losses will be recognized for businesses and manufacturing facilities in Hungary, Turkey and Japan.